Nuvalent director granted 3,444 RSUs

Protopapas Anna reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Protopapas Anna reported acquisition or exercise transactions in this Form 4 filing.

Nuvalent, Inc. director Anna Protopapas reported an equity award of 3,444 restricted stock units (RSUs) of Class A Common Stock. The award was recorded at a price of $0.00 per share, reflecting a compensation grant rather than a market purchase or sale.

Each RSU represents the right to receive one share of Nuvalent Class A Common Stock. The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent's next annual meeting of stockholders, subject to her continued service through the vesting date. Following this grant, she holds 8,590 shares directly.

Insider Trade Summary

Grant/Award: 3,444 shares

Grant/Award 1 txn

Insider Protopapas Anna

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	3,444	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 8,590 shares (Direct)

Footnotes (1)

1. F1. Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Key Figures

RSUs granted: 3,444 shares Total shares after grant: 8,590 shares Grant price: $0.00 per share +1 more

4 metrics

RSUs granted 3,444 shares Class A Common Stock award on June 16, 2026

Total shares after grant 8,590 shares Direct holdings following reported transaction

Grant price $0.00 per share Compensation grant, not a market purchase

RSU vesting date June 16, 2027 Earlier of this date or next annual meeting

Key Terms

restricted stock units ("RSUs"), Class A Common Stock, vest in full, annual meeting of stockholders

4 terms

restricted stock units ("RSUs") financial

"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Class A Common Stock financial

"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs")."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vest in full financial

"The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders."

annual meeting of stockholders financial

"The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nuvalent (NUVL) report for Anna Protopapas?

Nuvalent reported that director Anna Protopapas received 3,444 restricted stock units (RSUs) of Class A Common Stock. This is a compensation-related equity grant, not an open-market purchase or sale, and was recorded at $0.00 per share.

How many Nuvalent (NUVL) shares does Anna Protopapas hold after this Form 4?

After this award, Anna Protopapas holds 8,590 shares of Nuvalent Class A Common Stock directly. This total includes the newly granted 3,444 restricted stock units, which will convert into shares when they vest, assuming continued service.

When do the newly granted RSUs for Nuvalent (NUVL) vest?

The 3,444 RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent’s next annual meeting of stockholders, provided that Anna Protopapas continues to provide service to the company through the applicable vesting date.

What does the $0.00 per share price on the Nuvalent (NUVL) Form 4 mean?

The $0.00 per share price indicates a compensation grant, not a market transaction. These 3,444 RSUs were awarded to Anna Protopapas as equity compensation, so no cash changed hands when the units were granted.

What is an RSU in the context of Nuvalent (NUVL) insider filings?

Restricted stock units (RSUs) are promises to deliver shares in the future, typically after vesting conditions are met. Each Nuvalent RSU in this filing represents one share of Class A Common Stock that Protopapas will receive when the award vests.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Protopapas Anna

(Last) (First) (Middle)

C/O NUVALENT, INC.

ONE BROADWAY, 14TH FLOOR

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/16/2026		A		3,444(1)	A	$0.00	8,590	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

	/s/ Nathan N. McConarty, attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)